Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pall, A. A.
Right arrow Articles by Michael, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pall, A. A.
Right arrow Articles by Michael, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1994) 9: 770-774
© 1994 European Renal Association-European Dialysis and Transplant Association


research-article

Circulating soluble adhesion molecules in systemic vasculitis

A. A. Pall1, D. Adu, M. Drayson2, C. M. Taylor1, N. T. Richards1 and J. Michael1

1Renal Research Laboratories, Queen Elizabeth Hospital Edgbaston, Birmingham 2Department of Immunology, University of Birmingham Birmingham, UK

Correspondence and offprint requests to: Correspondence and offprint requests to Dr. D Adu, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK.

The plasma levels of soluble intercellular adhesion molecule-1 (sICAM-1), E-selectin (sE-selectin), and vascular cell adhesion molecule-1 (sVCAM-1), might reflect endothelial activation and injury and would therefore be useful markers of disease activity in vasculitis. To investigate this we measured the levels of sICAM-1, sE-selectin, and sVCAM-1 by two-site ELISAs in the plasma of patients with (a) active vasculitis (n = 16), (b) vasculitis in remission (n = 15), (c) chronic renal failure (CRF) (n = 10), and (d) normal healthy controls (n = 10). Plasma sICAM-1 levels were significantly higher in patients with active vasculitis, 323 ng/ml (193–607) compared with patients with inactive vasculitis, 199 ng/ml (131–297); P = 0.0006 and healthy controls, 188 ng/ml (138–259); P =0.0002. Plasma sE-selectin levels were also significantly higher in the patients with active vasculitis, 45 ng/ml (15–65) compared with patients with inactive vasculitis, 25 ng7sol;ml (15–55); P=0.027 but not when compared with healthy controls, 35 ng/ml (20–55); P=0.16. There was no difference in plasma sVCAM-1 levels between patients with active vasculitis, OD 0.56 (0.45–0.85) and inactive disease, OD 0.58 (0.47–0.79) (P=0.12) or with healthy controls OD 0.49 (0.42–0.68) (P=0.48). There were no significant differences between the plasma levels of any of the soluble adhe sion molecules between patients with active vasculitis and patients with chronic failure. In patients with a vasculitis there was a significant correlation between sICAM-1 and plasma C-reactive protein (CRP) (r=0.60, P=<0.01) and plasma von Willebrand factor (vWF) (r=0.42, P<0.05). Likewise there was a cor relation between sE-selectin and CRP (r=0.45, P<0.02) but not with vWF. There was a significant correlation between sICAM-1 and sE-selectin (r=0.38, P<0.05), but not between sICAM-1 and sVCAM-1 or sE- selectin and sVCAM-1. No correlation was found between sVCAM-1 levels and CRP and vWF concentrations or between the levels of any of the soluble adhesion molecules and serum creatinine. Plasma levels of sICAM-i and of sE-selectin but not of sVCAM-1 reflect disease activity in vasculitis and may be markers of endothelial and or tissue injury in these disorders.

Keywords: vasculitis; endothelium; adhesion molecules


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
J. Ara, E. Mirapeix, P. Arrizabalaga, R. Rodriguez, C. Ascaso, R. Abellana, J. Font, and A. Darnell
Circulating soluble adhesion molecules in ANCA-associated vasculitis
Nephrol. Dial. Transplant., February 1, 2001; 16(2): 276 - 285.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.